The Global HPAPI Summit
for Pharma Leaders
Two intensive days in Rome on containment, regulatory compliance, CDMO partnership and sustainable high-potency manufacturing.
Where the HPAPI
Industry Meets
Welcome to the 3rd Annual MaxPotent Pharma Summit, a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs).
This year’s edition builds on the strong foundation of our inaugural summit, with an expanded agenda designed to address the critical challenges and opportunities across the HPAPI value chain. Over two intensive days, the conference will highlight the latest developments in EU and global regulatory frameworks, emerging containment and isolation technologies, and state-of-the-art automation and process engineering that are transforming manufacturing practices.
Delegates will gain actionable insights from real-world case studies, panel discussions, and technical presentations covering occupational health and safety standards, scaling-up strategies, risk-based exposure assessments, and supply chain resilience. Particular emphasis will be placed on partnership models with CDMOs/CMOs, sustainability in high-potency operations, and the integration of digital tools and data-driven decision-making in pharma manufacturing.
Why this programme is different
Our team of producers and analysts invests over a year of preparation to study market dynamics, regulatory changes, and upcoming innovations. This invite-only summit is designed exclusively for HPAPI professionals who want to stay ahead of industry trends and strengthen their expertise. It is the essential platform for knowledge exchange, career advancement, and shaping the future of high-potency drug development.
More about the summitWhat the 2027 Programme Covers
Ten themes shape the two-day agenda, from EU regulatory frameworks to digital twins on the shop floor.
Evolving EU Regulatory Frameworks
Adapting to the latest EMA and ECHA requirements to ensure compliance in HPAPI production.
Innovative Containment Technologies
Designing next-generation facilities with advanced isolators and fully closed systems.
Building Supply Chain Resilience
Addressing challenges in sourcing, logistics, and cross-border disruptions affecting HPAPIs.
Harnessing AI and Machine Learning
Driving precision manufacturing through real-time analytics and process analytical technologies (PAT).
Protecting Workforce & Operations
Applying robust risk assessment methods to safeguard operators and minimise exposure risks.
Sustainability in HPAPI Manufacturing
Reducing environmental impact through waste management and alignment with EU Green Deal goals.
Six Reasons to Be in Rome
Master EU Regulatory Compliance
Understand the latest EMA and ECHA directives shaping HPAPI manufacturing, containment, and transport.
Advance Containment Excellence
Examine state-of-the-art facility designs, isolator systems, and closed technologies that safeguard operators while boosting efficiency.
Transform Manufacturing with AI & Automation
See how robotics, machine learning, and Process Analytical Technology (PAT) are redefining high-potency drug production.
Build Resilient Supply Chains & CDMO Alliances
Explore strategies for outsourcing, risk management, and reinforcing supply chain continuity across Europe.
Drive Sustainability in HPAPI Manufacturing
Implement greener practices in waste reduction, resource efficiency, and regulatory-aligned eco strategies.
Learn from Real-World Leaders
Gain practical insights through case studies and direct engagement with senior pharma executives, regulators, and innovators.
Built for the entire HPAPI value chain
Four groups meet in the same room for two days, and each one needs the other three.
Pharma & Biotech
R&D Directors, VP Manufacturing, Heads of Regulatory Affairs, CMC Leads
CMOs & CDMOs
Contract manufacturing leaders specialising in HPAPI handling, containment, and scale-up
Regulatory & EHS
EMA/ECHA compliance teams, occupational health scientists, risk assessment specialists
Tech & Equipment
Containment system vendors, isolator manufacturers, automation & PAT technology providers
Who will be in the room
Based on the delivered Milan editions. The Rome edition is expected to match and exceed these benchmarks.
Audience by sector
Seniority breakdown
The industry you operate in is growing fast
Projected market value driven by oncology, ADCs, and precision medicine demand
One of the fastest-growing segments across the global pharmaceutical industry
High-potency compounds now dominate oncology drug development pipelines globally
Active compounds in clinical and pre-clinical development requiring specialist expertise
Planned CDMO and containment facility investments across Europe over the next 5 years
Reported increase in occupational exposure events underscoring urgency of better containment
Speakers for Milan 2026
Building on the success of the MaxPotent Pharma Summit 2026 — which welcomed keynote presentations from industry leaders including Justin Mason-Home on strategic elements within HPAPI projects — the 2026 edition will feature an expanded faculty of 25+ expert speakers from pharma, biotech, CDMOs, and regulatory bodies. Speakers for May 2026 are currently being confirmed. If you are a recognised expert in HPAPI manufacturing, containment technologies, regulatory compliance, or occupational health, we invite you to apply to speak.
Manufacturing & Containment
Keynotes and technical presentations on next-generation containment systems, facility design, continuous processing, automation, and scale-up strategies for high-potency compounds.
Apply to SpeakRegulatory, Safety & Compliance
Expert sessions on evolving EMA and ECHA frameworks, risk-based exposure assessments, occupational health management, supply chain resilience, and CDMO partnership models.
Apply to SpeakAgenda at a Glance
Two intensive days spanning the full HPAPI value chain, from regulatory compliance and containment engineering to automation, sustainability and supply chain resilience.
23 more sessions across both days
Add your business email to unlock the full Rome 2027 programme, including every talk title and speaker slot.
We will send the PDF agenda across as well.
Drinks Reception
End of Day 1 from 17:30 — informal, relationship-first networking
1:1 Meetings
Structured matchmaking with sponsors, speakers, and delegates
Networking Lunches
Shared lunches both days — cross-industry connection opportunity
Sponsor Exhibition
Dedicated exhibition space running across both conference days
Glimpses of Milan 2026
Our 2026 inaugural edition brought together 300+ senior professionals at Duo Milan Porta Nuova for two days of scientific exchange and strategic networking.
Opening Keynote
Justin Mason-Home on strategic HPAPI project elements
Panel Discussion
Containment systems & occupational safety roundtable
Networking Reception
End-of-day drinks at Duo Milan Porta Nuova

Sponsor Exhibition
Live product demonstrations across both days
Why sponsor MaxPotent 2026
Sponsoring MaxPotent Pharma Summit places your brand at the centre of Europe's most focused HPAPI conference, with direct access to 300+ senior decision-makers you cannot reach anywhere else.
Speaking Access
Reserved branded speaking slot in the main programme (Platinum & Gold) — 30 minutes on Day 1.
Exhibition Space
Dedicated 10×6ft stand for live product demos and direct delegate engagement across both days.
Attendee List
Post-event delegate list with contact details for structured follow-up outreach after the summit.
1:1 Matchmaking
Up to 10 pre-arranged one-to-one meetings with your most relevant delegates and prospects.
Brand Visibility
Logo placement across the website, programme brochure, email campaigns, and all on-site materials.
Social Media Coverage
Pre and post-event coverage across MaxPotent's LinkedIn and email channels to 5,000+ subscribers.
What Sponsors and Delegates Say
The event was exceptionally well organised, offering ample networking opportunities with a large number of attendees and presenters. The hospitality was excellent, and it was a pleasure to interact with colleagues while highlighting the importance of toxicology in areas such as containment, risk assessment, and both worker and patient protection. We look forward to collaborating with Convolign on future events as well.
We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. The event brought together many customers, key manufacturers, and leading engineering companies, making it a great platform to exchange knowledge, information, and experience. We will definitely look forward to joining next year’s edition.
Congratulations to the entire team of Convolign Business Consulting for organising such a wonderful event. It was a perfect platform to gain insights into the key factors and technologies shaping high potent drug manufacturing. We also had excellent opportunities to network with peers and connect with new clients.
The event was highly informative, and we made some excellent industry contacts to introduce our systems to. The footfall was impressive, and the presentations were insightful. Overall, it was a great event for us, and we look forward to attending the next edition.
We had an excellent delegate turnout. The one-to-one meetings were very well organised and provided a great platform to connect with leaders from across various segments of HPAPI drug development. Truly a valuable opportunity for meaningful discussions and collaborations.
I found the event very engaging, with a wide range of interesting topics covered. The venue was excellent, offering plenty of opportunities for networking, and the hospitality was truly remarkable.
60+ Companies Represented to Date
A snapshot of the organisations that have joined the summit across its first two editions.
Why Rome for the Third Edition
The summit series moves to Rome for its third edition. Here is what that changes for the people travelling to it.
The first two editions proved the format in Milan, at the centre of Italy’s API manufacturing cluster. Rome widens the door. It is the best-connected city in Italy for international delegates, with two airports carrying direct flights from across Europe, the Americas and Asia, so the CDMO partners, regulators and technology providers who could not easily reach Milan can now attend without a connecting flight. Rome also puts the summit alongside the Lazio pharmaceutical corridor and within reach of the regulatory community, while offering the conference capacity and hotel choice that a growing delegation needs.
Two international airports
Rome Fiumicino (FCO) is Italy’s largest hub, with direct long-haul routes; Ciampino (CIA) adds low-cost European connections. Both are around 30 to 45 minutes from the centre.
High-speed rail across Italy
Roma Termini connects to Milan in about three hours, plus Florence, Bologna, Naples and Venice, so delegates can combine the summit with site visits.
A pharmaceutical corridor
Lazio hosts one of Italy’s densest concentrations of pharmaceutical manufacturing and contract development, alongside the containment and engineering specialists that serve it.
Capacity to grow
Rome gives the summit the conference space, hotel inventory and international flight access to expand the delegation beyond what the previous venues allowed.
Join us in Rome
Venue to be announced
The 3rd Annual MaxPotent Pharma Summit takes place in Rome on 21–22 April 2027. The venue is being finalised. Full venue and accommodation details are shared with registered delegates and confirmed sponsors as soon as they are confirmed.
Italy, a European HPAPI heartland
Italy hosts one of Europe’s densest concentrations of API and HPAPI contract manufacturers, from Lombardy to Lazio, alongside the engineering and containment specialists that serve them. That is why the summit series has made Italy its home since the inaugural Milan edition.
Get in touch
with our team
For registration enquiries, speaking opportunities or sponsorship packages, our team is ready to assist.
